# Dalton Venture

> Dalton Venture is a VC fund in Shanghai backing Health Care and Medical. See 142 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 142
- Last investment: Aug 2026
- Lead investor: 37%
- Last updated: Aug 2026
- Website: http://www.daltonventure.cn/

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

## Contacts

5 contacts available for Dalton Venture. Shizune tracks 2 team members at Dalton Venture. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dalton-venture?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $450k–$5M |
| Series A | $2.8M–$17M |
| Series B | $2.8M–$50M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 24 | 17% |
| Medical | 20 | 14% |
| Biotechnology | 14 | 10% |
| Medical Device | 10 | 7% |
| Manufacturing | 9 | 6% |

106 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 47 | 33% |
| Series A | 32 | 23% |
| Series B | 21 | 15% |
| Angel | 10 | 7% |
| Series C | 6 | 4% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 46 | 32% |
| India | 33 | 23% |
| Canada | 1 | 1% |
| Singapore | 1 | 1% |
| United Kingdom | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ning Huang | Founding Partner | 0 | https://shizune.co/investors/profile/ning-huang |
| Qi Sun | Founding Management Partner | 1 | https://shizune.co/investors/profile/qi-sun-8365 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NewPro | NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible. |  | Seed | Aug 04, 2026 |  |
| Active Technology | Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways. | $48.9M | Angel | Aug 03, 2026 |  |
| Gestala | Gestala is China’s first pioneer in ultrasound-based Brain-Computer Interface (BCI). We are dedicated to engineering a platform with full-brain read-write capabilities, offering transformative therapeutic modalities for neurological disorders. Beyond clinical impact, we aim to decode the neural code and pave the way for a symbiotic future wherebrain science and artificial intelligence converge. | $61.9M | Angel | Jul 03, 2026 |  |
| Kongshanci | Kongshanci specializes in non-invasive brain-computer interfaces and neuromodulation. |  | Series A | Jun 12, 2026 |  |
| Baiyao Technology | Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes. |  | Seed | Jun 05, 2026 |  |
| Bangyun Medical | Bangyun Medical focuses on the research, development, production and sales of high-end surgical wound closure consumables and instruments | $14.5M | Angel | Mar 31, 2026 |  |
| Kangweijian Bio | Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition. |  | Series B | Mar 16, 2026 |  |
| Gestala | Gestala is China’s first pioneer in ultrasound-based Brain-Computer Interface (BCI). We are dedicated to engineering a platform with full-brain read-write capabilities, offering transformative therapeutic modalities for neurological disorders. Beyond clinical impact, we aim to decode the neural code and pave the way for a symbiotic future wherebrain science and artificial intelligence converge. | $21.8M | Angel | Mar 12, 2026 |  |
| MaiKeWei Medical | MaiKeWei Medical is a national high-tech company. It has an entire system that includes production, sales, and R&D. |  | Angel | Mar 03, 2026 |  |
| KRay Gene | KRay Gene is an innovative biopharmaceutical company focused on the development of ophthalmic and cell therapy drugs, committed to advancing cutting-edge therapies through scientific research and translational medicine to address unmet medical needs. |  | Series A | Jan 21, 2026 |  |

10 of 142 investments shown.

## Co-investors
- [WaterBridge Ventures](https://shizune.co/investors/profile/waterbridge-ventures) — VC Fund, 78 deals together
- [Info Edge](https://shizune.co/investors/profile/info-edge) — VC Fund, 7 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 7 deals together
- [Peak XV Partners](https://shizune.co/investors/profile/sequoia-india-2) — VC Fund, 7 deals together
- [Yunqi Partners](https://shizune.co/investors/profile/yunqi-partners) — VC Fund, 7 deals together
- [Elevation Capital](https://shizune.co/investors/profile/elevation-capital-6e8a) — VC Fund, 6 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [All VC Funds in India](https://shizune.co/investors/vc-funds-india)
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [SaaS VC Funds in India](https://shizune.co/investors/saas-vc-funds-india)

## FAQ

### What does Dalton Venture invest in?

Dalton Venture invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 142 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Dalton Venture's check size?

Dalton Venture typically joins rounds of $450k–$5M at Seed, $2.8M–$17M at Series A and $2.8M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Dalton Venture participates in.

### How do I contact Dalton Venture?

Public channels for Dalton Venture include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Dalton Venture?

The team at Dalton Venture includes Ning Huang (Founding Partner) and Qi Sun (Founding Management Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co